Showing results (11-20 of 111) with videos related to
Sort By:
Pageof 12
Iscience|March 22, 2021
Dissociation of DNA damage sensing by endoglycosidase HPSEAlex Agelidis, Rahul K Suryawanshi, Chandrashekhar D Patil, et al.Chemistry & Biology|December 3, 2014
N-terminal ArgD peptides from the classical Staphylococcus aureus Agr system have cytotoxic and proinflammatory activitiesDavid J Gonzalez, Ross Corriden, Kathryn Akong-Moore, et al.Inflammatory Bowel Diseases|February 17, 2024
Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not VedolizumabCarlos G Gonzalez, Toer W Stevens, Bram Verstockt, et al.Molecular & Cellular Proteomics : MCP|March 6, 2026
Host Proteome Remodeling during Group A Streptococcus Skin InfectionConcepcion Sanchez, Igor H Wierzbicki, Charlie F Bayne, et al.ACS Nano|September 12, 2017
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific Effector ProteinsJohn D Lapek, Ronnie H Fang, Xiaoli Wei, et al.Microbiome|August 23, 2022
Location-specific signatures of Crohn's disease at a multi-omics scaleCarlos G Gonzalez, Robert H Mills, Qiyun Zhu, et al.Research Square|May 20, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement activation and inflammation modulatorsConcepcion Sanchez, Anaamika Campeau, Ru Liu-Bryan, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Proteome profiling identifies a link between the mitochondrial pathways and host-microbial sensor ELMO1 following Salmonella infectionSajan C Achi, Dominic McGrosso, Stefania Tocci, et al.Scientific Reports|October 19, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulatorsConcepcion Sanchez, Anaamika Campeau, Ru Liu-Bryan, et al.Nature Communications|October 14, 2015
Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramideRoss Corriden, Andrew Hollands, Joshua Olson, et al.Pageof 12